Aesculap Implant Systems' activL Artificial Disc receives FDA approval: 5 facts

Written by Anuja Vaidya | June 15, 2015 | Print  |

Aesculap Implant Systems received FDA approval for the activL Artificial Disc.

Here are five facts:

 

1. The device is intended for the treatment of one-level lumbar degenerative disc disease. It is designed as an alternative to spinal fusion surgery.

 

2. It features cobalt chromium endplates which are fixed on to a patient's vertebrae with bone-sparing spikes for initial stabilization.

 

3. It also features an ultra high molecular weight polyethylene core.

 

4. In the investigational device exemption trial, the device was shown to be as successful as conventional total disc replacement designs.

 

5. Aesculap Implant Systems develops spine and orthopedic implant technologies to treat complex disorders of the spine, hip and knee.

 

More articles on devices:
Blue Belt Technologies's STRIDE knee system used in 1k procedures — 5 quick facts
Integra LifeSciences, Smith & Newphew, NuVasive & more — 14 key notes
Smith & Nephew voluntarily removes BIRMINGHAM HIP Resurfacing System components: 5 things to know

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers